Featured Research

from universities, journals, and other organizations

No major complications in most teens undergoing weight-loss bariatric surgery, study suggests

Date:
November 4, 2013
Source:
The JAMA Network Journals
Summary:
Most severely obese teenagers who underwent bariatric weight-loss surgery experienced no major complications, according to a new study.

Most severely obese teenagers who underwent bariatric weight-loss surgery (WLS) experienced no major complications, according to a study published by JAMA Pediatrics, a JAMA Network publication.

WLS is being used to treat severely obese adolescents but there are limited data about the surgical safety of these procedures. The volume of adolescent WLS in the United States tripled from the late 1990s to 2003 and shows no decline, according to the study background.

Thomas H. Inge, M.D., Ph.D., of the Cincinnati Children's Hospital Medical Center, and colleagues examined the clinical characteristics of severely obese adolescents undergoing WLS and safety outcomes (complications) after surgery. The study included 242 teens (average age 17 years) whose median body mass index was 50.5. Fifty-one percent of the teens had four or more major co-existing conditions, the most common of which were high cholesterol, sleep apnea, back and joint pain, high blood pressure and fatty liver disease, according to the study.

Laparoscopic Roux-en-Y gastric bypass was performed in 66 percent of the teens, vertical sleeve gastrectomy in 28 percent and adjustable gastric banding in 6 percent of patients. No deaths were reported during the initial hospitalization or within 30 days of operation. Major complications, such as reoperation, were seen in 19 patients (8 percent) and minor complications, such as readmission for dehydration, were observed in 36 patients (15 percent), the study found.

"These data demonstrated that 92 percent of the 242 severely obese adolescents who underwent WLS did so without major complications. This safety profile, including a 5 percent rate of major inpatient morbidity, was demonstrated despite the presence of significant comorbidities and severity of obesity that exceeded that of most published adult and adolescent bariatric studies," the authors note.

Researchers suggest more studies need to be conducted to assess long-term outcomes for adolescents undergoing WLS.

In a related editorial, Michael G. Sarr, M.D., of the Mayor Clinic, Rochester, Minn., writes: "Inge and colleagues have shown that although minor and major complications do occur in the early postoperative period after weight-loss surgery, the mortality was nil and the morbidity was treatable and similar to that in adults."

'The adolescent years are crucial in the development of psychosocial and interpersonal skills, positive self-concept, and the vagaries of emotional processing in peer interaction. Severe obesity can disrupt these social practices and especially the resultant networking with peers that serves as the important foundation of later social integration and the feeling of individual identity and self-worth," Sarr continues.

"Adolescence is a crucial time for the development of the emotional as well as social foundation of later life; many of us maintain that the psychosocial retardation (or call it politically whatever you want -- handicap, isolation, impairment -- we all know what this means) probably needs to be considered on equal terms as are the more evident metabolic problems of severe obesity; they are all interrelated," Sarr concludes.


Story Source:

The above story is based on materials provided by The JAMA Network Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Thomas H. Inge, MD, PhD; Meg H. Zeller, PhD; Todd M. Jenkins, PhD; Michael Helmrath, MD; Mary L. Brandt, MD; Marc P. Michalsky, MD; Carroll M. Harmon, MD, PhD; Anita Courcoulas, MD; Mary Horlick, MD; Stavra A. Xanthakos, MD, MS; Larry Dolan, MD; Mark Mitsnefes, MD, MS; Sean J. Barnett, MD; Ralph Buncher, ScD. Perioperative Outcomes of Adolescents Undergoing Bariatric Surgery: The Teen–Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Study. JAMA Pediatrics, November 2013 DOI: 10.1001/jamapediatrics.2013.4296

Cite This Page:

The JAMA Network Journals. "No major complications in most teens undergoing weight-loss bariatric surgery, study suggests." ScienceDaily. ScienceDaily, 4 November 2013. <www.sciencedaily.com/releases/2013/11/131104112635.htm>.
The JAMA Network Journals. (2013, November 4). No major complications in most teens undergoing weight-loss bariatric surgery, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/11/131104112635.htm
The JAMA Network Journals. "No major complications in most teens undergoing weight-loss bariatric surgery, study suggests." ScienceDaily. www.sciencedaily.com/releases/2013/11/131104112635.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins